The use of Multidimensional Data to Identify the Molecular Biomarker for Pancreatic Ductal Adenocarcinoma

Abstract EN

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, and the patient has an extremely poor overall survival with a less than 5% 5-year survival rate.

Development of potential biomarkers provides a critical foundation for the diagnosis of PDAC.

In this project, we have adopted an integrative approach to simultaneously identify biomarker and generate testable hypothesis from multidimensional omics data.

We first examine genes for which expression levels are correlated with survival data.

The gene list was screened with TF regulation, predicted miRNA targets information, and KEGG pathways.

We identified that 273 candidate genes are correlated with patient survival data.

12 TF regulation gene sets, 11 miRNAs targets gene sets, and 15 KEGG pathways are enriched with these survival genes.

Notably, CEBPA/miRNA32/PER2 signaling to the clock rhythm qualifies this pathway as a suitable target for therapeutic intervention in PDAC.

PER2 expression was highly associated with survival data, thus representing a novel biomarker for earlier detection of PDAC.